Valuation: Amgen Inc.

Market Cap 23TCr 21TCr 19TCr 18TCr 33TCr 21,92300Cr 33TCr 2,32000Cr 91TCr 11,37800Cr 86TCr 85TCr 36,59500Cr P/E 2026 *
27.1x
P/E 2027 * 24.1x
Enterprise Value 27TCr 24TCr 23TCr 21TCr 39TCr 25,85800Cr 39TCr 2,73600Cr 1,06800Cr 13,42100Cr 1,02000Cr 1LCr 43,16400Cr EV / Sales 2026 *
6.97x
EV / Sales 2027 * 6.58x
Free-Float
99.77%
Yield 2026 *
2.37%
Yield 2027 * 2.5%
1 day-0.72%
1 week+0.20%
Current month-2.15%
1 month+7.70%
3 months+15.41%
6 months+16.51%
Current year+22.71%
1 week 30.36
Extreme 30.36
30.74
1 month 27.73
Extreme 27.73
31.38
Current year 23.95
Extreme 23.95
32.94
1 year 23.95
Extreme 23.95
32.94
3 years 23.95
Extreme 23.95
32.94
5 years 23.95
Extreme 23.95
32.94
10 years 23.95
Extreme 23.95
32.94
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
-0.72%+0.20% - - 22TCr
+3.62%+1.68%+48.80%+98.41% 1,04000Cr
+2.13%-1.76%+33.04%+61.88% 60TCr
+3.32%+4.47%+23.72%+91.59% 48TCr
+3.80%+3.21%+73.99%+41.69% 35TCr
+3.09%+3.03%+29.59%+45.42% 35TCr
+2.82%+2.20%+17.90%+40.15% 27TCr
+3.40%+0.99%-3.44%+12.08% 24TCr
+3.21%+3.15%+45.01%+49.99% 22TCr
+3.80%+4.56%+29.59%+97.73% 18TCr
Average +2.64%+1.90%+33.13%+59.88% 41.59TCr
Weighted average by Cap. +2.47%+1.53%+36.79%+68.68%

Financials

2026 *2027 *
Net sales 3.9TCr 3.5TCr 3.27TCr 2.96TCr 5.56TCr 3,70900Cr 5.6TCr 39TCr 15TCr 1,92500Cr 15TCr 14TCr 6,19100Cr 4.04TCr 3.63TCr 3.39TCr 3.07TCr 5.77TCr 3,84400Cr 5.8TCr 41TCr 16TCr 1,99500Cr 15TCr 15TCr 6,41700Cr
Net income 854.02Cr 767.85Cr 716.56Cr 649.44Cr 1.22TCr 81TCr 1.23TCr 8.6TCr 3.36TCr 42TCr 3.21TCr 3.14TCr 1,35700Cr 942.6Cr 847.49Cr 790.89Cr 716.8Cr 1.35TCr 90TCr 1.35TCr 9.49TCr 3.71TCr 47TCr 3.54TCr 3.46TCr 1,49700Cr
Net Debt 4.14TCr 3.72TCr 3.47TCr 3.14TCr 5.9TCr 3,93600Cr 5.94TCr 42TCr 16TCr 2,04300Cr 16TCr 15TCr 6,57000Cr 3.55TCr 3.19TCr 2.98TCr 2.7TCr 5.07TCr 3,37600Cr 5.1TCr 36TCr 14TCr 1,75200Cr 13TCr 13TCr 5,63600Cr
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
13/26/13 CA$30.48 -0.72% 2,801
09/26/09 CA$30.70 +2.20% 6,629
08/26/08 CA$30.04 -1.25% 1,771
07/26/07 CA$30.42 +2.39% 2,913
06/26/06 CA$29.71 -0.30% 903
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
426.11USD
Average target price
394.77USD
Spread / Average Target
-7.35%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.